In glioma models, mPEG-PCL nanoparticles (~135 nm) co-loaded with resveratrol and temozolomide acted synergistically by inhibiting the PI3K/Akt/mTOR signaling pathway, increasing pro-apoptotic protein expression, and delaying tumor progression in U87 xenograft mice [247]. Here, AKT1 is linked to neoplasm.